A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value. - Wikidata - awgldk - TriplyDB

A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value.

A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value.

http://www.wikidata.org/entity/Q38976994

about

Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia Prognostic significance of huntingtin interacting protein 1 expression on patients with acute myeloid leukemia.Role of FDG PET/CT in Diagnostic Evaluation of Granulocytic Sarcomas: A Series of 12 Patients.MPI depletion enhances O-GlcNAcylation of p53 and suppresses the Warburg effect.6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells.Impact of Chemotherapy Delay on Overall Survival for AML with IDH1/2 Mutations: A Study in Adult Chinese Patients.The pan-class I phosphatidyl-inositol-3 kinase inhibitor NVP-BKM120 demonstrates anti-leukemic activity in acute myeloid leukemia.Cytoplasmic proliferating cell nuclear antigen connects glycolysis and cell survival in acute myeloid leukemia.The pretransplant systemic metabolic profile reflects a risk of acute graft versus host disease after allogeneic stem cell transplantation.High Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid Leukemia.Prognostic impact of MYH9 expression on patients with acute myeloid leukemia.Targeting of cell metabolism in human acute myeloid leukemia--more than targeting of isocitrate dehydrogenase mutations and PI3K/AKT/mTOR signaling?Fighting against hematological malignancy in China: from unique system to global impact.High expression of CPNE3 predicts adverse prognosis in acute myeloid leukemia.Synergistic cell death in FLT3-ITD positive acute myeloid leukemia by combined treatment with metformin and 6-benzylthioinosine.Enhanced Fructose Utilization Mediated by SLC2A5 Is a Unique Metabolic Feature of Acute Myeloid Leukemia with Therapeutic Potential.Cell intrinsic and extrinsic regulation of leukemia cell metabolism.Serum stearic acid/palmitic acid ratio as a potential predictor of diabetes remission after Roux-en-Y gastric bypass in obesity.Serum nuclear magnetic resonance-based metabolomics and outcome in diffuse large B-cell lymphoma patients - a pilot study.Metabonomics reveals metabolite changes in biliary atresia infants.High IDH1 expression is associated with a poor prognosis in cytogenetically normal acute myeloid leukemia.Integrating a prospective pilot trial and patient-derived xenografts to trace metabolic changes associated with acute myeloid leukemia.Pharmacometabolomics identifies dodecanamide and leukotriene B4 dimethylamide as a predictor of chemosensitivity for patients with acute myeloid leukemia treated with cytarabine and anthracycline.MicroRNA-181 as a prognostic biomarker for survival in acute myeloid leukemia: a meta-analysis.Resistance to the Antiproliferative In Vitro Effect of PI3K-Akt-mTOR Inhibition in Primary Human Acute Myeloid Leukemia Cells Is Associated with Altered Cell Metabolism.Novel non-neutral mitochondrial DNA mutations found in childhood acute lymphoblastic leukemia.Reduced expression of NR4A1 activates glycolytic pathway in acute promyelocytic leukemia cells.High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts.High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells.Metabolic Fingerprinting on a Plasmonic Gold Chip for Mass Spectrometry Based in Vitro Diagnostics.Therapeutic targeting of leukemic stem cells in acute myeloid leukemia - the biological background for possible strategies.Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia.CXCL12 promotes glycolytic reprogramming in acute myeloid leukemia cells via the CXCR4/mTOR axis.VEGF signaling in acute leukemia: mitochondrial connections.Serum NMR metabolomics to differentiate haematologic malignancies.Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine The Ins and Outs of Autophagy and Metabolism in Hematopoietic and Leukemic Stem Cells: Food for Thought Analysis of the Metabolic Characteristics of Serum Samples in Patients With Multiple Myeloma Clonal Heterogeneity Reflected by PI3K-AKT-mTOR Signaling in Human Acute Myeloid Leukemia Cells and Its Association with Adverse Prognosis Signalling mechanisms that regulate metabolic profile and autophagy of acute myeloid leukaemia cells

P2860

Q30276873-CB712E5B-5740-4FA1-B7D4-47FEDCFC4F25 Q30847181-2053428A-C240-4AE1-A6CF-7D9FF08DDCAB Q33827749-0DE559DE-22B7-4378-A719-2D1F57348FDD Q33866466-B92F1809-3B5D-4EFB-AF36-6E152FFD9EC8 Q35749994-1FCB761C-8DBC-46BE-9668-C83F95B00A86 Q35806875-B47D8193-58C6-4874-BC87-DD847B79544E Q36379644-B5D716A1-8824-4C0E-B844-105F620E2326 Q37349113-CC52A49E-D57F-4096-887A-61AC8C156A78 Q37366244-FAE37B03-8BD2-4CD0-89C5-2A4A1E16EE52 Q37510247-C90B955B-31D6-4141-9CB5-A392228A07D5 Q37702129-DBBD48D2-32D6-47E5-9278-89B8DA669EAF Q38606849-EE84B5CA-E2EB-405A-983B-CC5C0E91BC10 Q38632968-E9AF9A53-DAFE-43BF-907B-E41BB902013A Q38697273-0A8C0600-FA51-4822-970A-D6F21E6412AB Q38736840-F2743343-B0CF-45E5-9029-E14C9DDA1919 Q38740919-15E24D2F-7AC1-43EE-A2F8-607C8F56A550 Q38742000-E8073199-DB10-44ED-A848-D4CE511ECEEE Q39070560-FA350925-1195-4048-8A95-E962D2006B00 Q39989686-C014C824-D23F-4F59-A889-1033090D2566 Q41300611-C8DB2F22-A47E-4D42-97C5-43F8A281F4D0 Q41670609-DE4899AA-AFB1-4D38-B162-56B7DC1CF83A Q42378226-F37371C4-2A31-41EF-8502-F8B991DB527A Q46769583-0B9F7EB5-80CA-4B30-8956-DF22D522F3EB Q47100861-CF4A44EE-BF8E-4331-9A32-5B8AE0993FEE Q48043104-2D189272-2182-46B4-9F7F-95FDB9B78A9B Q48057726-7AB316C5-CBAB-45DA-8642-969FE8C26D38 Q48174492-08ADE5FD-08F1-45A9-8631-2765D0773E80 Q50061766-C78A9DF9-BFA5-4421-B19D-8272DE9AB045 Q51103239-3A19C784-ED65-487B-8B45-891483F01FD1 Q51417509-AB131CDA-633C-415A-8839-45E6B6F69B30 Q51818965-47B2CB4A-EC01-4C92-8A99-7FA9150F7DF9 Q52608845-38530D5F-F148-469A-AB84-D2825803B4A0 Q53154264-A12BC2D4-0D7C-4991-A13D-30FD4A834DBE Q54965419-C568165A-F679-436A-BD17-EEFD4CFA7293 Q55102185-C240CE02-6FC7-4FE0-88F5-9D2A2525DBE7 Q57461758-7400F98F-59D3-4021-9171-D3214B67AF57 Q57491369-09E90AC9-7ACF-4853-B0FE-8B28C4F64177 Q58719351-C3841AB1-000A-4323-9327-F82B504A0508 Q58739036-4EF89BE4-E142-4C84-86A8-5E4D4A49519B Q58767624-AF12292C-96BC-4164-A2C4-824F52A1EA3A

P2860

A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value.

http://www.wikidata.org/entity/Q38976994

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value.

@en

type

label

A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value.

@en

prefLabel

A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value.

@en

P1433

Q38976994-D9176568-28B1-45BA-9DBD-885C54574544

P1476

Q38976994-623B7775-B24B-4BEA-9A66-F23B995D8708

P2093

Q38976994-0974428D-72B6-47C5-9030-DF5A559A6CCC

Q38976994-0D799805-ADDB-4359-8F22-0ED6EE8DD8B3

Q38976994-161D8362-FD10-4214-82CC-B337F1C790ED

Q38976994-1C55D011-B646-4393-ABAC-C11DA693C69E

Q38976994-284C5EAA-A25E-46EB-B3A5-7848B0C78D22

Q38976994-2B817939-B2ED-45CF-A3DB-0697F5D471A5

Q38976994-381CB129-D73C-42DF-B692-821E9BA8E846

Q38976994-47734812-6BD6-4E8A-B84F-34014B7F1F69

Q38976994-48179CFF-8ED6-4CA4-ABAA-764F54C8CE85

Q38976994-4A8C3379-AC8A-44A8-8D0D-BCA5D94F7108

P2860

Q38976994-0E4B05F8-B4DA-4838-9888-D80B49C078E7

Q38976994-131323AA-835B-42D6-8995-26414EB08D9F

Q38976994-16947A94-FD7E-472F-A673-C434A33449B2

Q38976994-22C771D1-1F4F-45DB-86A6-BDA458A016B4

Q38976994-262F182B-2D6C-4417-8C38-24CCB16B2B32

Q38976994-2DBD1273-9650-4B32-A24A-0ACF78963F57

Q38976994-4247D0E5-BC5A-48E1-81EE-B0CF3FB9A547

Q38976994-54E8985C-9A3E-4908-84C2-A014A88FD394

Q38976994-5B48D362-BBA2-45E5-A324-6A94EE43B59B

Q38976994-5B8BF96B-74C3-4C39-A8E9-9D88A3C0E853

P304

Q38976994-FEA9A1BD-AA17-4818-9877-7DF993B96978

P31

Q38976994-9C3FE983-D2DA-45A9-904D-D206A445B5BA

P356

Q38976994-92D56EE0-E17D-4995-AD89-120FC129BF89

P407

Q38976994-6A02E3FD-A531-45B3-8F23-4483BA733081

P433

Q38976994-3E1A5309-C53E-4DD0-B9DB-57131352A682

P478

Q38976994-91FC6B4B-FD01-43E9-9844-E8A5B72D66A2

P50

Q38976994-88142937-5F85-403B-BD1A-D5A99685D28A

P577

Q38976994-ED699BD3-5080-40DB-B651-F203BDEB1B9B

P5875

Q38976994-134883C6-C570-460E-B7ED-926DD6AC9BEA

P698

Q38976994-C5D4FF1C-DD18-4C10-A882-6187A90988C7

P921

Q38976994-598eba65-e0a2-4a0a-9311-1711b0110c68

Q38976994-C584FCE9-8D47-4B9A-B410-FC71C318D105

Q38976994-ECDA5E1B-2BAA-41F0-B732-DFCA47AD9DCF

P932

Q38976994-97A753B8-520F-4B7F-8D9F-C62878499C0F

P356

BLOOD-2014-02-554204

P1433

P1476

A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value

@en

P2093

Ai-Hua Zhao

http://www.w3.org/2001/XMLSchema#string

Bing-Shun Wang

http://www.w3.org/2001/XMLSchema#string

De-Pei Wu

http://www.w3.org/2001/XMLSchema#string

He Huang

http://www.w3.org/2001/XMLSchema#string

Jian-Qing Mi

http://www.w3.org/2001/XMLSchema#string

Jian-Yong Li

http://www.w3.org/2001/XMLSchema#string

Jie Jin

http://www.w3.org/2001/XMLSchema#string

Jin-Song Yan

http://www.w3.org/2001/XMLSchema#string

Jing-Han Wang

http://www.w3.org/2001/XMLSchema#string

Jun-Min Li

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Cytoscape: a software environment for integrated models of biomolecular interaction networks

Targeting cellular metabolism to improve cancer therapeutics

MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

Semi-supervised methods to predict patient survival from gene expression data

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation

P304

1645-1654

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2014-02-554204

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263779199

http://www.w3.org/2001/XMLSchema#string

P698

25006128

http://www.w3.org/2001/XMLSchema#string

P921

P932

5726328

http://www.w3.org/2001/XMLSchema#string